X

Trial Profile

A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Bipolar I Disorder

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Brexpiprazole (Primary)
Indications Bipolar I disorders
Focus Adverse reactions; Registrational
Sponsors Otsuka Pharmaceutical Development & Commercialization

Most Recent Events

30 Apr 2020 Status changed from active, no longer recruiting to completed.
24 Sep 2019 This trial was completed in Bulgaria (end date: 2019-07-31), according to European Clinical Trials Database.
10 Apr 2019 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com